- Perspectives
- Thomas A. Ban: A brief historical exchange between Larry Stein and Joseph Knoll.
- Thomas A. Ban: In historical perspective. Peralta, Cuesta and their Associates findings on the highest familiality of Leonhard’s classification in polynosologic study.
- Thomas A. Ban: The Ewen Cameron Story..
- Thomas A. Ban: The RDoC in historical perspective.
- Barry Blackwell’s comment on de Leon J, Wise TN, Balon R, Fava G: Dealing with Difficult Medical Colleagues published in Psychotherapy and Psychosomatics
- Barry Blackwell: Risk and relevance to lithium usage.
- Barry Blackwell’s comment (Harvey V. Fineberg: Conflict of Interest: Why Does It Matter? Viewpoint. JAMA 2017; 317: 8)
- W. Edwin Fann A History of The Tennessee Neuropsychiatric Institute.
- Samuel Gershon’s comments on Ronald Pies’ “Do antipsychotics thin the brain?” Journal of Clinical Psychopharmacology 2018; 38 (3): 167- 9.
- Laszlo Gyermek: The role of the tropane skeleton in drug research
- Carlos R. Hojaij: Ethics for psychiatrists.
- Gerd Huber and Gisela Gross: The Development of the Psychopathology in Germany in the Last Decades [20th century] with an Introduction by Carlos R. Hojaij.
- Martin M. Katz’s comment on Jose de Leon’s article “Focusing on drug versus disease mechanisms and on clinical subtyping to advance personalized medicine”
- Carl Lange: On periodical depressions and their pathogenesis Speech delivered to the ‘Medical Society of Copenhagen', 19 January 1886.
- Alex Last: BBC Witness History. The First Antipsychotic Drug. An interview of Thomas Ban..
- Carlos Morra: Argentina’s controversial National Law of Mental Health No. 26, 657..
- János Radó’s comment on Lin, Zhang, Feng, et al., “Aliskiren increases aquaporin-2 expression and attenuates lithium-induced nephrogenic diabetes insipidus.”
- Janos Radó: Mechanism of Lithium Induced Polyuria in Historical Perspective.
- Janusz Rybakowski: Emil Kraepelin's dichotomy of “endogenous psychoses” in historical perspective.
- Mary Seeman’s comment on Jack R. Foucher et al.’s paper on Wernicke-Kleist-Leonhard phenotypes of endogenous psychoses: A review of their validity.
- Philip Seeman and Mary V. Seeman: The Dopamine Hypothesis of Schizophrenia in Historical Perspective.
- Edward Shorter’s comment on Jack R. Foucher et al.’s paper on Wernicke-Kleist-Leonhard phenotypes of endogenous psychoses: A review of their validity.
- Hector Warnes’ comment on Silberman, Balon, Starcevic et al “Benzodiazepines: it ́s time to return to the evidence.”
Laszlo Gyermek: The role of the tropane skeleton in drug research
CLICK HERE TO OPEN THE DOCUMENT
November 14, 2019